Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Related Pain (Breakthrough Pain)”

Showing 8 of 0 results

Large-scale testing (Phase 3)Study completedNCT01326689
What this trial is testing

A Comparative Study of KW-2246

Who this might be right for
Cancer Related Pain (Breakthrough Pain)
Kyowa Kirin Co., Ltd. 42
Large-scale testing (Phase 3)Study completedNCT00538863
What this trial is testing

Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

Who this might be right for
CancerPain
INSYS Therapeutics Inc 319
Large-scale testing (Phase 3)Study completedNCT00683995
What this trial is testing

A Phase III Clinical Study of KW-2246

Who this might be right for
Pain, Cancer
Kyowa Kirin Co., Ltd. 43
Large-scale testing (Phase 3)Study completedNCT00696137
What this trial is testing

Long-term Extension Study of BEMA™ Fentanyl

Who this might be right for
Respiratory Depression
BioDelivery Sciences International 5
Not applicableStudy completedNCT04595032
What this trial is testing

MAnagement of METastatic Disease in Campania (MAMETIC)

Who this might be right for
Metastatic Disease
National Cancer Institute, Naples 3,234
Testing effectiveness (Phase 2)Ended earlyNCT00351637
What this trial is testing

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

Who this might be right for
CancerPain
Alberta Health services 60
Not applicableEnded earlyNCT04468490
What this trial is testing

Treatment of Breakthrough Cancer Pain According to European Guidelines

Who this might be right for
Breakthrough Cancer Pain
Aziende Chimiche Riunite Angelini Francesco S.p.A 131
Not applicableStudy completedNCT03435120
What this trial is testing

Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)

Who this might be right for
Breakthrough Pain
Angelini Farmacéutica 118

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation